Last reviewed · How we verify
Humedil (benzpiperylone)
Humedil (generic name: benzpiperylone) is a benzpiperylone drug. It is currently in unknown development.
Humedil is thought to work by interacting with a specific target in the body, although the exact nature of this interaction is not well understood.
Humedil is a small molecule with the synonyms BENZOPIPERILONE, BENZPIPERILONA, BENZPIPERYLON, BENZPIPERYLONE, KB 95, and KB-95.
At a glance
| Generic name | benzpiperylone |
|---|---|
| Drug class | benzpiperylone |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine Humedil as a key that fits into a lock in the body. When it binds to this lock, it can either turn it on or off, or change the way it works. This can have different effects depending on the lock and what it controls.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Humedil CI brief — competitive landscape report
- Humedil updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Humedil
What is Humedil?
How does Humedil work?
What is the generic name of Humedil?
What drug class is Humedil in?
What development phase is Humedil in?
Related
- Drug class: All benzpiperylone drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing